As 2025 gets underway, reconnecting with key accounts is top of mind for many. For oncology drug manufacturers, having the right tools to navigate these conversations is critical. That’s where our Integrated Delivery Network (IDN) Dataset comes in, providing the insights and clarity you need to drive meaningful engagement with 147 unique IDNs.
What Makes the IDN Dataset Stand Out?
The dataset includes comprehensive demographic and process data tailored to help you better understand and connect with IDNs, including:
This online dashboard enables you to anticipate and address the needs of IDN stakeholders effectively.
Key Features at Your Fingertips
Our IDN-at-a-Glance Dashboard, accessible via our online portal, simplifies preparation for account teams by offering:
Now Available in Snowflake
We’ve enhanced accessibility by making our dataset available in Snowflake.
Looking Ahead
As IDNs face increasing complexity in oncology management, having a strategic approach backed by actionable insights is critical. Our dataset doesn’t just offer data—it equips your teams with the tools to anticipate challenges and seize opportunities.
Have questions? Reach out to our team or learn more about the portal with our IDN dataset overview! Send me a note at ebijesse@hmpglobal.com.
As manufacturers prepare for Medicare drug price negotiations, a critical question emerges: How will your provider engagement strategy evolve when Maximum Fair Prices (MFP) take effect in 2026?
Emma BijesseOne of Cindy’s favorite parts of working at HMP Market Access Insights is being part of a small, close-knit team. Collaborating with colleagues from different backgrounds has helped her expand her framework for viewing research.
Cindy ChenChris passionately dig deeply into research to uncover nuggets of information that can make a real difference. His favorite part of the job? Interacting with clients and helping them view challenges through a fresh lens.
Chris Van Denburg